The following Wall St. Journal article presents both views about stem
cell research and hints at why it is difficult to find statements by
candidates on this issue. Also about another Parkinson's advocate in
COngress - Sen. Gordon Smith (Rep.) of Oregon, and why this year's
election in the U.S.  is a Parkinson's issue.

Put to the Test: GOP Avoids Abortion For Now, but Science Is Stirring the
Debate --- Research That Kills Embryos But May Fight Diseases Prompts
Reassessments --- A Senator and His Conscience
Wall Street Journal
Eastern edition
Aug 1, 2000
By Bob Davis
p.  A1

  PHILADELPHIA -- Republicans may have called a truce in their civil war
over abortion, but don't expect it to hold. Scientific advances are
reshaping
abortion politics.

   Consider Sen. Gordon Smith. The National Right to Life Committee says
the Oregon Republican voted the right way on abortion every time last
year.
But when an Oregon antiabortion activist asked him a few weeks ago to
defend
a prohibition on extracting stem cells from human embryos because the
procedure kills the embryos, he declined. Someday, he told her,
researchers might be able to turn such cells into neurons that would
relieve the Parkinson's
disease that has ravaged his family.

   "I've had many people who have died slowly," he told the activist.
"Part
of my pro-life ethic is to make life better for the living."

   The debate over abortion has roiled Republican conventions since the
Roe vs. Wade Supreme Court decision of 1973. This year, George W. Bush
persuaded delegates to bury the issue by leaving unchanged the
antiabortion
language included in previous party platforms. The less time taken up
with
the abortion question, he and other Republican leaders felt, the better.
The platform committee voted down all proposals by abortion-rights
advocates,
including one to simply "welcome people on all sides of this complex
issue."
Mr. Bush, says Maryland delegate Ellen Sauerbrey, "was trying to avoid
abortion becoming the center of the campaign."

   Even if he succeeds, new fronts are opening in the debate. Genetic
technology
is deepening ethical dilemmas and opening fissures within the
antiabortion
movement, and even within the abortion-rights side.

   Over the next few years, for instance, prenatal tests will be
developed
that can detect whether fetuses are prone to develop breast cancer and
other maladies when they become adults. Unlike the familiar Down's
syndrome
test, which gives a yes or no answer, the new tests will reveal only the
odds for developing a condition, and one that wouldn't arrive for years.
While the new tests won't change anything for those dead-set against
abortion,
they could complicate the issue for others.

   There is also a gathering controversy over so-called therapeutic
cloning.
Scientists would clone an embryo of a patient, which would essentially
be used for spare parts or to test new treatments, and be destroyed in
the process. A British biomedical advisory group is expected to recommend
that the U.K. government endorse work on the technology.

   In the U.S., the next big abortion fight is likely to focus on the
discovery
in late 1998 that stem cells -- precursor cells that can develop into
brain,
blood and any other tissue -- can be harvested from human embryos stored
at fertility clinics. Since the harvesting kills the embryo, the
technology
raises in a new way the intimate question at the heart of the abortion
debate: When, if ever, is it acceptable to sacrifice the unborn?

   The presidential candidates line up in predictable ways. Gov. Bush,
an abortion foe, opposes the new technology. Vice President Gore, an
abortion-rights advocate, supports it. But some others in the
antiabortion and abortion-rights camps are struggling with the issue and
re-examining their views.

   Using stem cells, scientists are working to develop replacements for
tissue damaged in Alzheimer's disease, Parkinson's, diabetes and other
conditions. The cells also might be useful following chemotherapy for
cancer.
Thus, the abortion debate doesn't involve just a woman and her embryo or
fetus. This new technology brings in another party: a disease-sufferer
who might benefit from tissue collected from embryos or fetuses.

   Citing the promise of the new technology, Sen. Smith and a few other
antiabortion Republicans whose families have been battered by disease
have
declined to support a blanket opposition to stem-cell research with
embryos.
They include Sen. Strom Thurmond of South Carolina, whose daughter has
diabetes, Sen. Connie Mack of Florida, whose family is riddled with
cancer,
and Rep. Duke Cunningham of California, a prostate-cancer survivor. Some
other antiabortion Republicans are privately offering their backing for
embryo research, as well.

   "There's a weakening on the part of pro-family groups on this issue,"
agrees conservative activist Paul Weyrich.

   Opponents of embryo research see it as an especially pernicious
assault
on life and sometimes cast their foes as sellouts. "Where are you
ethically
when you have an emotional hurt [because of disease] and you abandon your
ethics?" asks Rep. Tom Coburn, an Oklahoma Republican, who is also a
family
doctor. Kansas Republican Sen. Sam Brownback says that if the government
endorses research that destroys embryos, it will be categorizing a form
of human life as "property" that can be used guilt-free for
experimentation.
The Republican platform applauds GOP lawmakers "for the steps they have
taken for the protection of human embryos" but doesn't mention the
stem-cell
controversy.

   Meanwhile, a staunch supporter of abortion rights, the United
Methodist
Church, has come out against stem-cell research. "Human embryo research
is a big step toward making human life a commodity," says Jaydee Hanson,
senior staffer on the church's bioethics task force.

   Sen. Smith's struggle to find his way in this scrambled abortion
debate
shows the splits that are beginning to develop among Republicans. The
48-year-old
Mr. Smith is a devout Mormon who served two years as a missionary in New
Zealand. He keeps an ornate Bible by his desk and consults it regularly.
Noting that two basic Mormon tenets are free choice and the sanctity of
life, he says that "there's no issue that brings these two principles in
conflict as much as abortion."

   Abortion politics have played a central role in Mr. Smith's career.
He rose to prominence in Oregon by pushing through the state Senate a law
requiring minors to get parental consent for abortions. In his first U.S.
Senate bid in early 1996 (when Bob Packwood resigned), Mr. Smith allied
himself with the right wing, attacked abortion and gay rights, and lost.
Later that year, he ran for Oregon's other Senate seat, soft-pedaled
abortion
-- and won.

   He arrived in Washington with a zealot's reputation. But he was always
a more complicated political figure, particularly on abortion.

   As a child, Mr. Smith had seen his mother, who had already given birth
to seven children, grow resentful over not having a legal option for
ending
an especially difficult pregnancy. "She felt devalued," he recalls.

   He is also haunted by the specter of Parkinson's disease. It took the
lives of his grandmother and a cousin, Rep. Morris Udall, and some other
Udall family members. A favorite uncle is now incapacitated with it. Sen.
Smith sees research on embryos as a source of hope for Parkinson's
patients.
But he worries about whether he is being true to his antiabortion views.
"There's a human life, a child of God at stake," he says.

   The stem-cell debate mirrors one on research involving fetal tissue.
The Bush adminstration imposed a ban on fetal research, which Bill
Clinton
lifted when he took office. Since then, researchers have tried implanting
fetal tissue in the brains of Parkinson's sufferers, hoping to ease a
deficiency
of the neurotransmitter dopamine. Thus far, younger patients have
benefited
somewhat, but not people over 60.

   A more promising idea arrived in late 1998. In a feat that Science
magazine
called the breakthrough of the year, two scientifc teams harvested stem
cells from embryos (from fertility clinics) and aborted fetuses, and
coaxed
the cells to grow in the laboratory. Parkinson's researchers believed
that
if they injected stem cells into patients, the highly flexible precursor
cells might grow into dopamine-producing neurons. Ron McKay, a National
Institutes of Health researcher, has done this with mice and alleviated
Parkinson's-like tremors.

   But 1996 legislation, which has been renewed annually, bars federal
funding for research that destroys embryos, so Dr. McKay can't try his
technique in humans. To him, "It's a pity to take the vast government
research
effort and prevent it from being applied to this useful technology."

   Now, the NIH has plotted a way around the restriction. The agency has
proposed new rules allowing it to give grants to researchers who get
their
stem cells from other, non-federally funded scientists. Abortion foes,
considering this hairsplitting, have organized letter-writing campaigns
that have deluged the NIH with complaints. But the agency is expected to
adopt the rules this summer.

   At the same time, Republican Sen. Arlen Specter of Pennsylvania and
Democratic Sen. Tom Harkin of Iowa are pushing a bill to lift the ban on
federal funding of embryo research. It might come to a vote in September.

   On a recent day, this brewing battle brings Gayle Atteberry, executive
director of the Oregon Right to Life Committee, to Sen. Smith's office.
A longtime friend of Mr. Smith, she begins to draw a diagram for him of
how an impregnated egg develops into an embryo. She stops suddenly, looks
him in the eye and says: "A fertilized egg that has divided is being
snatched
away. It's dead."

   "Is there no room in your view" for another opinion, the senator asks.

   How could there be, she replies. She reads a verse from Psalm 139,
where
the psalmist says of God, "Your eyes saw my unformed body." Even when a
human is an "unformed substance," she says, it is divinely blessed.

   Sen. Smith, a soft-spoken man who shuns confrontation, tries to
explain
his own theology, influenced by a Mormon Church elder who is a heart
surgeon.
The senator believes the soul infuses a fetus around the time its blood
starts circulating, or about six weeks after conception. His
interpretation
would allow scientists to destroy embryos without violating religious
injunctions.
"When He put the spirit in the body is the critical question for me,"
Sen.
Smith says. "I have never thought of cells frozen in a refrigerator as
human life. If it isn't life, it isn't killing."

   "What else is it?" Ms. Atteberry asks.

   "If I cut my finger, I'm not ending life."

   "But that finger can't develop into a human life," she replies.

   Nonplused, she unwraps a gift she has brought the senator: Dr. Seuss's
"Horton Hears a Who." She quietly repeats the refrain, "A person's a
person,
no matter how small." In the same way, she says, even tiny embryos
deserve
protection. The book is a favorite of his, too, he tells her, and leaves
it at that.

   Ms. Atteberry tries a more pragmatic approach. Scientists have
discovered
stem cells in adults, too, she says. Why not focus research on those,
rather
than ones found in embryos? He listens but is noncommittal. After she
leaves,
he says he wants to move forward on stem cells no matter what their
origin,
and plans to fight for the Specter/Harkin bill. Scientists worry that
stem
cells from adults won't be as adaptable and long-lived as those taken
from
embryos. "We need to do what works," he says.

   The stance may cost him politically among antiabortion conservatives,
but gain him support among the state's more-numerous moderates. "Smith
doesn't have solid principles," says Lon Mabon, chairman of the Oregon
Citizens Alliance, a conservative group that backed his first Senate run
and opposed his second. But Mr. Mabon acknowledges that "a lot of the
pro-life
community in Oregon is moving to where Sen. Smith is."

   Sen. Smith's main foe in the stem-cell debate is Sen. Brownback of
Kansas.
An earnest Methodist, the Kansan says he prayed before testifying in
April
at a hearing chaired by Sen. Specter. "At the very center of the debate,"
he testified, is the question: "Is the young human a person or property?"

   Two months later, he made a similar plea to a weekly meeting of Senate
Republicans. The government should focus on adult-stem-cell research, he
told them, and let embryos alone. After he was done, participants say,
Sen. Mack of Florida replied: "I have many of the beliefs of Sam, but the
door should be left open to research," including that involving embryos.
Sen. Mack didn't mention that he, his wife and his daughter are cancer
survivors, but Sen. Smith says other lawmakers knew of Sen. Mack's
struggles
with the disease.

   Thus far, the stem-cell supporters have been quietly effective. Rep.
Jay Dickey, an Arkansas Republican who sponsored the ban on
embryo-destroying
research, hasn't taken action on his threat to broaden it to halt NIH's
rule-making. His aides say he has decided to rely on the courts to upset
the new NIH rules. But some conservative activists and other
congressional
aides say Mr. Dickey doesn't have the votes.

   Medical-research lobbyists who want the ban lifted are keeping their
distance from abortion-rights groups, to avoid scaring off pro-life
Republicans.
Instead, they recruit patients as advocates for their position. Sen.
Smith
had a visit two weeks ago from one such advocate, Joan Samuelson of the
Michael J. Fox Foundation for Parkinson's Research. Sitting on one of her
hands to make a tremor from Parkinson's less noticeable, she expressed
her frustration that the NIH wasn't making more progress against the
disease.

   The senator promised to do what he could, mindful of the toll that
Parkinson's
is currently taking on a 79-year-old uncle of his, Addison Udall. Mr.
Udall
is so ill he can no longer walk or talk. Yet in an indication of how
difficult
the issue is, Mr. Udall's wife, Ada, says that she has "mixed emotions"
about stem-cell research, even though that could combat the disease
ravaging
her husband. "That fertilized embryo could become a person," she says.